About
David Yang is a partner at Lux focused on therapeutics, R&D tools and biopharma infrastructure, while operating as a generalist. He previously co-founded and led strategy and operations at gene therapy company Latus Bio, worked on viral diagnostics tools at the Broad Institute, and holds a degree from Harvard.
Invests in
AI & Machine LearningBiotechDeep TechDefense TechEnergyHardwareRobotics
Investments
Investor
AndurilApplied IntuitionAurisChronosphereCognitionEikonHugging FaceImpulse SpacePhysical IntelligenceRunwaySakanaTogether
Per the firm's website.
Colleagues at Lux Capital
Adam Kalish
Partner, Capital Formation at Lux Capital
Ale Salardi
Executive Assistant at Lux Capital
Alex Nguyen
Partner at Lux Capital
Andrew Wilson
Partner, Legal at Lux Capital
Bibi Masara
Office Manager at Lux Capital
Bilal Zuberi
General Partner at Lux Capital
Brad Gritsch
Finance at Lux Capital
Brandon Reeves
Partner at Lux Capital
Network11
Brandon ReevesScout
Partner at Lux Capital
Danny CrichtonScout
Partner, Research at Lux Capital, publishing the Securities newsletter and Riskgaming
Deena ShakirScout
Partner at Lux Capital
Josh WolfeScout
Partner and Co-Founder at Lux Capital
Shahin FarshchiScout
Partner at Lux Capital
Alex Nguyen
Partner at Lux Capital
Bilal Zuberi
General Partner at Lux Capital
Grace Isford
Partner at Lux Capital
Ian Peikon
Venture Partner at Lux Capital
Lan Jiang
Partner at Lux Capital
Tess van Stekelenburg
Partner at Lux Capital
Investors connected to David in public investor directories — a warm-intro map.